Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001082038-19-000017
Filing Date
2019-06-20
Accepted
2019-06-20 18:09:57
Documents
1
Period of Report
2019-06-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3727
  Complete submission text file 0001082038-19-000017.txt   5007
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Issuer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 RESULTS WAY CUPERTINO CA 95014
Business Address
Blaschke Terrence F (Reporting) CIK: 0001382523 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31615 | Film No.: 19909497